【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Disease Overview
06.1 Understanding the Disease
06.2 Etiology and Risk Factors
06.2.1 Modifiable Risk Factors
06.2.2 Non-modifiable Risk Factors
06.3 Pathophysiology
06.4 Signs and Symptoms
06.5 Diagnosis
06.5.1 ECG
06.5.2 Stress Testing
06.5.3 Echocardiography
06.5.4 Chest X-Ray
06.5.5 Blood Tests
06.5.6 Coronary Angiography and Cardiac Catheterization
06.6 Management
06.6.1 Lifestyle Changes
06.6.2 Pharmacotherapy
06.6.3 Medical Procedures
06.7 Epidemiology
06.8 Economic Burden
07.Pipeline Analysis
07.1 Information on Pipeline Candidates
07.1.1 ONO-1101
07.1.2 Ranolazine
07.1.3 Autologous CD34+ stem cells
07.1.4 Generx
07.1.5 Cryocell
07.1.6 RVX-208
07.1.7 MPSK3169A
07.1.8 GS-6615
07.1.9 JVS-100
07.1.10 LA-419
07.1.11 ALD-201
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Disease Class
09.1 Angina Pectoris
09.1.1 Stable Angina
09.1.2 Unstable Angina
09.1.3 Prinzmetal’s Angina
09.2 MI
09.2.1 STEMI
09.2.2 NSTEMI
10.Market Segmentation by Drug Class
10.1 Anti-dyslipidemic Drugs
10.2 Calcium Channel Blockers
10.3 Beta-blockers
10.4 ACE Inhibitors
10.5 ARBs
10.6 Vasodilators
10.7 Antithrombotic Agents
11.Geographical Segmentation
12.Buying Criteria
13.Market Growth Drivers
14.Drivers and their Impact
15.Market Challenges
16.Impact of Drivers and Challenges
17.Market Trends
18.Trends and their Impact
19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.2.1 AstraZeneca
19.2.2 Bayer
19.2.3 Eli Lilly
19.2.4 Novartis
19.2.5 Pfizer
19.2.6 Sanofi
19.3 Other and Future Prominent Vendors
20.Global IHD Drugs Market: Key Takeaways
21.Key Vendor Analysis
21.1 AstraZeneca plc
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation by Revenue 2013
21.1.4 Business Segmentation by Revenue 2011-2013
21.1.5 Sales by Geography
21.1.6 Business Strategy
21.1.7 Key Developments
21.1.8 SWOT Analysis
21.2 Bayer
21.2.1 Key facts
21.2.2 Business overview
21.2.3 Business segmentation by revenue 2014
21.2.4 Business segmentation by revenue 2013 and 2014
21.2.5 Geographical segmentation by revenue 2014
21.2.6 Business strategy
21.2.7 Recent developments
21.2.8 SWOT analysis
21.3 Eli Lilly
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue
21.3.4 Sales by Geography
21.3.5 Business Strategy
21.3.6 Key Information
21.3.7 SWOT Analysis
21.4 Novartis AG
21.4.1 Key Facts
21.4.2 Business Description
21.4.3 Business Segmentation
21.4.4 Revenue by Business Segmentation
21.4.5 Revenue Comparison 2012 and 2013
21.4.6 Sales by Geography
21.4.7 Business Strategy
21.4.8 Key Developments
21.4.9 SWOT Analysis
21.5 Pfizer
21.5.1 Key facts
21.5.2 Business overview
21.5.3 Business segmentation by revenue 2014
21.5.4 Business segmentation by revenue 2013 and 2014
21.5.5 Geographical segmentation by revenue 2014
21.5.6 Business strategy
21.5.7 Key developments
21.5.8 SWOT analysis
21.6 Sanofi SA
21.6.1 Key Facts
21.6.2 Business Description
21.6.3 Business Segmentation
21.6.4 Revenue by Business Segmentation
21.6.5 Revenue Comparison 2012 and 2013
21.6.6 Sales by Geography
21.6.7 Business Strategy
21.6.8 Key Developments
21.6.9 SWOT Analysis
22.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Overview of IHD
Exhibit 3: Pathophysiology of IHD
Exhibit 4: Leading Cause of Death in World 2012
Exhibit 5: Leading Cause of Death in US 2013
Exhibit 6: Pipeline Portfolio of IHD Drugs
Exhibit 7: Global IHD Drugs Market 2014-2019 ($ millions)
Exhibit 8: Global IHD Drugs Market Segment by Disease Class
Exhibit 9: Global IHD Drugs Market Segment by Drug Class
Exhibit 10: Segmentation of Global IHD Drugs Market by Geography 2014
Exhibit 11: YoY Growth and Revenue of Atacand 2010-2014 ($ millions)
Exhibit 12: YoY Growth and Revenue of Crestor 2010-2014 ($ millions)
Exhibit 13: YoY Growth and Revenue of Seloken/Toprol-XL 2010-2014 ($ millions)
Exhibit 14: YoY Growth and Revenue of Adalat 2010-2014 ($ millions)
Exhibit 15: YoY Growth and Revenue of Xarelto 2010-2014 ($ millions)
Exhibit 16: YoY Growth and Revenue of Effient 2010-2014 ($ millions)
Exhibit 17: YoY Growth and Revenue of Diovan 2010-2014 ($ millions)
Exhibit 18: YoY Growth and Revenue of Exforge 2010-2014 ($ millions)
Exhibit 19: YoY Growth and Revenue of Caduet 2010-2014 ($ millions)
Exhibit 20: YoY Growth and Revenue of Fragmin 2010-2014 ($ millions)
Exhibit 21: YoY Growth and Revenue of Lipitor 2010-2014 ($ millions)
Exhibit 22: YoY Growth and Revenue of Norvasc 2010-2014 ($ millions)
Exhibit 23: YoY Growth and Revenue of Lovenox 2010-2014 ($ millions)
Exhibit 24: YoY Growth and Revenue of Plavix 2010-2014 ($ millions)
Exhibit 25: Global IHD Drugs Market: Key Takeaways
Exhibit 26: AstraZeneca plc: Business Segmentation by Revenue 2013
Exhibit 27: AstraZeneca plc: Business Segmentation by Revenue 2011-2013 ($ millions)
Exhibit 28: AstraZeneca plc: Sales by Geography 2013
Exhibit 29: Bayer: Business segmentation by revenue 2014
Exhibit 30: Bayer: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 31: Bayer: Geographical segmentation by revenue 2014
Exhibit 32: Eli Lilly: Business Segmentation by Revenue 2013
Exhibit 33: Eli Lilly: Business Segmentation by Revenue 2012 and 2013 ($ millions)
Exhibit 34: Eli Lilly: Sales by Geography 2013
Exhibit 35: Novartis AG: Business Segmentation
Exhibit 36: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 37: Novartis AG: Revenue by Business Segmentation 2012 and 2013 ($ millions)
Exhibit 38: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 39: Pfizer: Business segmentation by revenue 2014
Exhibit 40: Pfizer: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 41: Pfizer: Geographical segmentation by revenue 2014
Exhibit 42: Sanofi SA: Business Segmentation
Exhibit 43: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 44: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 ($ millions)
Exhibit 45: Sanofi SA: Sales Revenue by Geographical Segmentation 2013
【レポート販売概要】
■ タイトル：虚血性心疾患（IHD）治療薬の世界市場2015-2019■ 英文：Global Ischemic Heart Disease (IHD)Drugs Market 2015-2019
■ 発行日：2015年7月29日
■ 調査会社：Technavio
■ 商品コード：IRTNTR6611
■ 調査対象地域：グローバル
- 建設装置レンタルの世界市場分析：製品別（土木工事、マテリアルハンドリング、コンクリート･道路建設）、セグメント予測The construction equipment rental market is expected to reach USD 84.60 billion by 2022, according to a new study by Grand View Research, Inc. Availability of wider range of modern, productive machinery in rental fleets coupled with infrastructural development occurring at brisk pace is projected to drive demand. Significant factors such as the cost inflation associated with the replacement of equ …
- 高電圧送電システムの世界市場：高圧交流送電（HVAC）、高圧直流送電 （HVDC）、高圧スイッチギヤ、高圧遮断器、変電所自動化、海底ケーブル等About High Voltage Transmission Systems The bulk transfer of electrical energy from the point of generation to electrical substations is termed as electric transmission. Generally, this transmission occurs at very high voltage levels to minimize losses. High voltage transmission systems refers to all the major equipment used to carry out the entire task of electric power transmission. It includes …
- 世界の小型自動車用OEミラー市場【2015年1月更新版】This latest just-auto report edition offers a global review of the OE mirrors sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE mirrors market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prospects Marke …
- 世界の頭蓋内圧力監視装置市場：医療機器パイプライン分析2016Intracranial Pressure Monitoring Devices - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Intracranial Pressure Monitoring Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of Intracranial Pressure Monitoring Devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with compar …
- 心血管超音波画像システムの世界市場2019-2023About this market The technological advances in the cardiovascular ultrasound imaging systems is likely to push growth in the market. Vendors are coming up with innovative and better technologies to overcome the shortcomings of old systems. Technavio’s analysts have predicted that the cardiovascular ultrasound imaging systems market will register a CAGR of more than 5% by 2023. Market Overview Inc …
- エラストマーの世界市場予測（～2021）：種類別（熱硬化（天然ゴム、合成ゴム（スチレンブタジエンゴムSBR、ブチルゴムIIR、ビニルピリジンとブタジエンとのゴム状共重合体PBR、ニトリルゴムNBR、アクリル酸エステルゴムACM、エチレンとプロピレンとのゴム状共重合体EPM））および熱可塑性プラスチック（ポリアミド12エラストマーPEBA、スチレンブロック共重合体SBC、サーモポリオレフィンTPO、熱可塑性ポリウレタンTPU、熱可塑性加硫エラストマーTPV））、用途別（自動車、一般消費財、医療、産業）“The growing use of elastomers in the automotive industries is a key factor for the growth of the elastomers market”The global elastomers market size (2016–2021) is estimated to reach USD 92.36 billion by 2021, at a CAGR of 4.6% from 2016 to 2021. The growth of the market can be attributed to the increasing adoption of elastomers across applications, such as automotive, medical, and industrial, ow …
- 世界のフレキシブル包装市場動向：Global Flexible Packaging Market 2014-2018TechNavio's analysts forecast the Global Flexible Packaging market to grow at a CAGR of 4.95 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in demand for convenience in packaging. The Global Flexible Packaging market has also been witnessing the growing concern for environmentally friendly packaging. However, the highly fragmented marke …
- TEaaS（クラウド式テスト環境サービス）の世界市場2016-2020About the Test Environment as a Service Market Testing as a service (TEaaS) is an on-demand cloud-based service to manage end-to-end software test environments. Test environments are created during the software testing process to enable software testers to use testing tools and executive testing processes successfully and to develop high-quality software products and applications. Firms are using …
- クラウド実現技術の世界市場2017-2021ABSTRACTAbout Cloud Enabling Technologies Cloud computing is the use of computing resources that are delivered to customers with the help of Internet. The evolution of cloud computing has led to the emergence of cloud-enabling technologies such as virtualization, automated computing, and service-oriented architecture (SOA) technologies. Cloud computing enables enterprises to use these technologies …
- PetroEnergy Resources Corporation：石油・ガスの開発・生産動向及びコスト分析- 2012PetroEnergy Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary PetroEnergy Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is …
- JordanのPotassium Hydroxide (Caustic Potash)市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Jordan and its perspectives on the global market for potassium hydroxide (caustic potash). The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on potassium hydroxide (caustic potash) export/import operations in Jordan …
- 虫垂炎(Appendicitis)：世界の治験レビュー（2015年上半期版）Appendicitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Appendicitis Global Clinical Trials Review, H1, 2015" provides data on the Appendicitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Appendicitis. It includes an overview of the trial numbers and their recruitment status as per the sit …
- 世界のデータガバナンス市場：コンポーネント別、展開モデル別、組織規模別、用途別（リスク管理、インシデント管理、コンプライアンス管理）、業種別（製造、ヘルスケア、BFSI）、地域別The global data governance market size to grow at a CAGR of 21.5% during the forecast period The data governance market size is projected to grow from USD 1.8 billion in 2019 to USD 4.8 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 21.5% during the forecast period. The data governance market is driven by growing regulatory compliance and privacy concerns for data security. However, t …
- 石油・ガス産業向け漏れ検出技術の世界市場予測（～2022年）“Leak detection market for oil and gas expected to grow at a significant rate between 2016 and 2022” The leak detection market for oil and gas was valued at 2.10 billion in 2015 and is expected to reach USD 3.38 billion by 2022, at a CAGR of 6.9% between 2016 and 2022. The growth of this market can be attributed to the increasing incidents of leakages in the oil and gas pipelines and storage tanks …
- 世界の中小企業IT支出市場（2014-2018）About SMBs Small and medium-sized (SMB) businesses are defined based on the number of employees and annual revenue generated. Micro businesses are those that have less than 10 employees, small businesses are those that employ less than 100 employees, and mid-sized businesses are those that have more than 100 but less than 1,000 employees. The IT requirement of an SMB differs based on business size …
